Search results
2 maj 2018 · Decrease of portal pressure by shunt procedures. The most effective measure to reduce portal hypertension is to circumvent the increased intrahepatic resistance in liver cirrhosis and bypass the blood into the inferior vena cava by portacaval, mesocaval, or proximal splenorenal shunts.
2 paź 2022 · In Western nations, portal hypertension is most commonly caused by cirrhosis of the liver. That’s when long-term liver disease causes scarring of your liver tissues. Scar tissue obstructs the flow of blood through the portal vein running through your liver.
1 kwi 2019 · Portal hypertension is a major complication of cirrhosis, and its consequences, including ascites, esophageal varices, hepatic encephalopathy, and hepatorenal syndrome, lead to substantial morbidity and mortality.
10 paź 2020 · Portal hypertension is a life-threatening complication of cirrhosis, characterized by splanchnic vasodilatation, the formation of varices and variceal bleeding, which account for much of the mortality and morbidity in cirrhotic patients.
30 maj 2024 · Portal hypertension often develops in the setting of cirrhosis, schistosomiasis, or extrahepatic portal vein thrombosis. It is the result of resistance to portal blood flow and may lead to complications such as variceal bleeding and ascites.
17 kwi 2024 · Portal hypertension represents the primary non-neoplastic complication of liver cirrhosis and has life-threatening consequences, such as oesophageal variceal bleeding, ascites, and hepatic encephalopathy.
Treatment of early stages of portal hypertension focuses on controlling the underlying etiology of liver cirrhosis. Owing to the regenerative capability of the liver, etiologic cure may result in fibrosis regression thus reversing the structural component of portal hypertension.
